Synergistic activity of crocin and crocin loaded in niosomes alone and in combination with fluconazole against Candida albicans isolates: In vitro and in silico study

Introduction: Since the drug resistance in Candida species is becoming a serious clinical challenge, novel alternative therapeutic options, particularly herbal medicine, have attracted increasing interest. This study aimed to pinpoint the potential antifungal activity of crocin (Cro), the efficacy of the niosomal formulation of Cro (N-Cro), and the synergistic activity of both formulations in combination with fluconazole (FLC) against susceptible and resistant C. albicans isolates. Material and methods: N-Cro was formulated using the heating method. The in vitro antimycotic activity of Cro, N-Cro, and FLC was evaluated. Checkerboard and isobologram assays evaluated the interaction between both formulations of Cro and FLC. Necrotic and apoptotic effects of different agents were analyzed using the flow cytometry method. In silico study was performed to examine the interactions between Lanosterol 14 alpha-demethylase and Cro as a part of our screening compounds with antifungal properties. Results: N-Cro exhibited high entrapment efficiency up to 99.73 +/- 0.54, and the mean size at 5.224 +/- 0.618 mu m (mean +/- SD, n = 3). Both formulations of Cro were shown to display good anticandidal activity against isolates. The synergistic effect of the N-Cro in combination with FLC is comparable to Cro (P-value =0.03). Apoptotic indicators confirmed that tested compounds caused cell death in isolates. The docking study indicated that Cro has interactivity with the protein residue of 14 alpha-demethylase. Conclusion: The results showed a remarkable antifungal effect by N-Cro combined with FLC. Natural compounds, particularly nano-sized carrier systems, can act as an effective therapeutic option for further optimizing fungal infection treatment. (c) 2024 SFMM. Published by Elsevier Masson SAS. All rights reserved.